MetLife Investment Advisors »

Capricor Therapeutics shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Capricor Therapeutics (CAPR) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Capricor Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Capricor Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Capricor Therapeutics by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $103k 14k 7.21
2025-06-30 $221k 22k 9.93
2025-03-31 $211k 22k 9.49
2024-12-31 $313k 23k 13.80